Cohance Lifesciences
COHANCENSE

Cohance Lifesciences

₹418.55-1.35 (0.32%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
416.60
Today’s high
424.00
52 week low
266.70
52 week high
1,121.15
Open price
424.00
Previous close
419.90
Live volume
4,61,210
Lower circuit
334.85
Upper circuit
502.25

Fundamentals

Market Cap
₹16,010Cr
ROE
5.05%
P/E Ratio(TTM)
106.76
EPS(TTM)
3.92
P/B Ratio
4.09
Dividend Yield
0.00%
Industry P/E
34.62
Book Value
102.24
Debt to Equity
0.10
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹617
+12.09%
Profit (Cr)
₹8.31
-71.36%
02505007501k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-28%
3Y CAGR-4%
Profit growthValue
1Y (TTM)-93%
3Y CAGR-16%

About

Cohance Lifesciences Limited is a contract development and manufacturing organization (CDMO) and API manufacturer.;
CEO/MD
Dr. V. Prasada Raju
Founded in
2020
NSE symbol
COHANCE

Shareholding Pattern

May '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
57.49%
Mutual Funds
18.57%
Retail And Others
15.13%
Foreign Institutions
5.59%
Other Domestic Institutions
3.22%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹461.85
-8.35 (1.78%)
L
    H
    18,605.7358.753.84
    ₹520.05
    -1.30 (0.25%)
    L
      H
      8,190.0031.942.47
      ₹441.05
      +1.10 (0.25%)
      L
        H
        7,642.0226.046.09
        ₹6,887.00
        +29.00 (0.42%)
        L
          H
          1,82,775.1273.7311.86
          Livesquawk
          Jefferies downgrades Cohance Life to Underperform, lowering target price to ₹300 due to weak Q4 results. Challenges include Specialty Chemicals decline, management churn, tough FY27 outlook, and 14–17% EPS cuts for FY27–28.
          Livesquawk
          Cohance Lifesciences Q4 net profit drops to 195M vs 1.2B YoY. Q4 revenue declines to 6.2B rupees from 8.4B YoY.
          2026
          12
          May
          Quarterly & Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks